Based on demographic factors and blood tests, several scoring systems for the assessment of fibrosis or cirrhosis in NAFLD have been proposed: NAFLD fibrosis score (NFS), fibrosis-4-score (FIB-4), BARD (BMI-AST/ALT-Diabetes), enhanced liver fibrosis panel (ELF), Hepascore, Fibro MeterTM, Fibro TestTM, and so on [51]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.